This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Levi Knippel, Ph.D
Senior Scientist at Merck
Speaker

Profile

James Levi Knippel is a senior scientist in the small-molecule process research and development group at Merck. Throughout his time at Merck, he has supported the commercial process development of enlicitide (MK-0616). He earned his BA and MA in chemistry from Johns Hopkins University, where he studied radical fluorination. He then earned his Ph.D. in chemistry from MIT, studying asymmetric catalysis in the lab of Stephen Buchwald.

Agenda Sessions

  • Development of a Multi-Enzyme Cascade En-Route to Enlicitide (MK-0616)

    9:30am